DOI: https://dx.doi.org/10.18203/2320-6012.ijrms20220992
Published: 2022-03-28

Conjunctival autograft for recurrent conjunctival granuloma

Stevie Kresentia, Amir Surya

Abstract


Pyogenic granuloma is a benign vascular tumour that can arise from several reasons and tends not to transform into malignant. These tumours, which are more common in young people, may also recur. Just like in this case, a 39-year-old man came with a mass on his left eyeball that had been enlarged since two weeks ago. He also had a history of surgery on his left eye one month ago. From the examination results, the visual acuity was 5/5 and a 2mm, reddish, firmed border mass on the bulbar conjunctiva at the nasal area. He was diagnosed with conjunctival granuloma and we decided to do tumour excision and also histopathology examination. The histopathology results specified a granuloma. Three weeks later, there was the same mass growth but more prominent. We decided to re-excise with a conjunctival autograft and administered ophthalmic and oral steroids to minimize the recurrence. One month after surgery, the conjunctival graft had already fused with the surrounding conjunctiva without oedema, and five months later, no new granuloma growth was seen. This method can be considered for patient’s comfort and cosmetics but still requires further research and a larger number of samples to ensure the accuracy of the data.


Keywords


Recurrent conjunctival granuloma, Pyogenic granuloma, Conjunctival autograft

Full Text:

PDF

References


Tidake PK, Jaiswal S, Wagh V. Conjunctival Pyogenic Granuloma-A Case Report. J Evol Med Dent Sci. 2021;10(2):111-3.

Dhivya Ashok Kumar HT, Agarwal A. A rare case of symptomatic ocular pyogenic granuloma in pregnancy. BMC Ophthalmol. 2017;17(1):1.

Jaiswal H, Patidar N, Shah C, Singh R, Jain EPP. Topical timolol 0.5% as the primary treatment of ophthalmic pyogenic granuloma: A prospective, single‑arm study. BMC Ophthalmol. 2017;17(1):1.

Rao PR, Furniturewala AU, Gopinathan I, Nair AG. Conjunctival Pyogenic Granuloma Masquerading as Malignant Melanoma. Cureus. 2021;13(8):8-11.

Carol L, Shields JAS. Tumors of the conjunctiva and cornea. BMC Ophthalmol. 2017;17(1):1.

Wu D, Qian T, Nakao T, Xu J, Liu Z, Sun X et al. Medically uncontrolled conjunctival pyogenic granulomas: Correlation between clinical characteristics and histological findings. Oncotarget. 2017;8(2):2020-4.

Suman S, Kumar A. Intraoperative mitomycin C and cryotherapy as adjunct therapy for recurrent lobular capillary haemangioma of conjunctiva. BMJ Case Rep. 2020;13(1):1-4.

Nair AG, George RJ, Natarajan SVJ. Topical timolol for the treatment of conjunctival pyogenic granulomas: Outcomes and effect on intraocular pressure. BMC Ophthalmol. 2017;17(1):1.

Chen Z, Wang T, Pan Q, Zhang Z, Zhang Z. Clinicopathologic characteristics and surgical outcome of synthetic fiber conjunctival granuloma. BMC Ophthalmol. 2020;20(1):1-7.

Shi C, Ren Y, Feng J, Guo W, Zheng X. Conjunctival granulomatous capillary haemangioma in children: case report and review of the literature. BMC Pediatr. 2021;21(1):1-6.

Lee Y, Hyon JY, Jeon HS. Conjunctival Pyogenic Granuloma: Cases with Undetermined Etiologies. Korean J Ophthalmol. 2019;33(5):483.

Röck T, Bramkamp M, Bartz-Schmidt KU, Röck D. A retrospective study to compare the recurrence rate after treatment of pterygium by conjunctival autograft, primary closure, and amniotic membrane transplantation. Med Sci Monit. 2019;25:7976-81.

Kodavoor SK, Preethi VRD. Efficacy of second donor conjunctival graft from the same site for pterygium‑A retrospective analysis. BMC Ophthalmol. 2017;17(1):1.

Lee JS, Ha SW, Yu S, Lee GJ, Park YJ. Efficacy and Safety of a Large Conjunctival Autograft for Recurrent Pterygium. Korean J Ophthalmol. 2017;31(6):469.